Mycospectrum Majewski Spółka Komandytowa (KRS 0000948352, NIP 7262689503) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. MYCOSPECTRUM MAJEWSKI operates in: Other human health activities n.e.c. (PKD 86.90.E). Industry: Healthcare. The company has been listed in the National Court Register since January 20, 2022. MYCOSPECTRUM MAJEWSKI's most recently reported net revenue was 1.8 M PLN for 2024. MYCOSPECTRUM MAJEWSKI's operations are currently suspended.
The company is currently suspended
Suspended since December 29, 2025
Negative equity
Negative equity in 6 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Mycospectrum Majewski
Identity
- Name
- Mycospectrum Majewski Spółka Komandytowa
- Legal form
- SPÓŁKA KOMANDYTOWA
- Founded
- January 20, 2022
- Registry status as of
- May 14, 2026
- Latest entry
- May 13, 2026
- Founding act
- 20.01.2022R.
Articles of association history (1)
- January 20, 2022: 20.01.2022R.
Activities
Main activity
86.90.EOther human health activities n.e.c.
Other activities
Address and contact
- Address
- UL. ŚWITEZIANKI, 8, 87, 91-496, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-66036-13645-BHIHW-21
Risk and payment profile - Mycospectrum Majewski
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/4 yrs
Board changes
0
0/4 yrs
PKD changes
0
0/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Trade credit limit history
Standard limit from 2018–2024
Current: 92.2 K PLN
Safe: 16.1 K PLN
Operational status - Mycospectrum Majewski
Founded
January 20, 2022
4 years in operation
Legal form
SPÓŁKA KOMANDYTOWA
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
86.90.E
Other human health activities n.e.c.
Share capital
N/A
Shareholders
N/A
Board
1 person
Filed years
7 years
2018–2024 · profitable: 4/7
Registry entries
14
latest: May 13, 2026
Risk signals
Revenue
1.8 M PLN
2024
Net profit
266.0 K PLN
2024
Assets
250.0 K PLN
2024
Equity
19.6 K PLN
2024
Valuation
0 PLN
suspended
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Mycospectrum Majewski.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
